APLT (Applied Therapeutics Inc.) Earnings per share growth this year

Applied Therapeutics specializes in developing agents that prevent toxin accumulation in metabolic pathologies. The year-over-year earnings per share growth rate demonstrates yield dynamics, where the 18.40 mark records this indicator. Success is based on recruiting leading biochemists to develop patents, while the company's ethical image ensures high loyalty from the patient and investor communities.

APLT (appliedtherapeutics.com) Earnings per share growth in current year history from 07/04/2022 to 02/16/2026

Financial and market metric breakdowns for Applied Therapeutics (APLT)

- stock value and consensus price forecast:

Market Price Applied Therapeutics Inc.|APLT - Analyst Consensus Forecast

- business market valuation indicators:

Market Capitalization Applied Therapeutics, Inc.|APLT - Real Price to Acquire Entire Company

- book capitalization information:

Accounting Value of a Share Applied Therapeutics|APLT - Company Book Value|Market Capitalization to Net Assets appliedtherapeutics.com|APLT - Company Total Assets

- debt and solvency information:

- net income and valuation multiples indicators:

APLT - Net Profit|Projected Future Earnings Applied Therapeutics|APLT - Price to Earnings Ratio|Price to Expected Earnings Ratio Applied Therapeutics Inc.|APLT - Price/Earnings to Growth Ratio|Company Value to Operating Income Before Depreciation Ratio Applied Therapeutics, Inc.|APLT - Profit before payment of interest, taxes and amortization|Earnings per share for the last twelve months Applied Therapeutics|APLT - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months appliedtherapeutics.com|APLT - Earnings growth in current year|Expected net earnings per share growth next year Applied Therapeutics

Basic company analysis:Applied Therapeutics Inc. (APLT)

Manufactured products of Applied Therapeutics

The implementation of AI in Applied Therapeutics (APLT) molecule screening accelerates drug development while optimizing costs. EPS dynamics measure the percentage deviation of current earnings per share from the same period last year. This indicator assesses capital management efficiency and the strategy's adaptability to market shocks. Growth in this metric confirms the success of production automation while maintaining physician control. By analyzing the annual earnings per share growth profile, an investor determines business sustainability.

Main competitors